FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022359041> ?p ?o ?g. }

• W2022359041 endingPage "413" @default.
• W2022359041 startingPage "403" @default.
• W2022359041 abstract "1. Cytochrome P450 (CYP) 3A catalysis of testosterone 6beta-hydroxylation in female rat liver microsomes was significantly induced, then reached a plateau level after pretreatment with 80 mg kg(-1) day(-1) dexamethasone (DEX) for 3 days. 2. Midazolam was mainly metabolized by CYP3A in DEX-treated female rat liver microsomes from an immuno-inhibition study, and the apparent K(m) was 1.8 microM, similar to that in human microsomes. 3. Ketoconazole and erythromycin, typical CYP3A inhibitors, demonstrated extensive inhibition of midazolam metabolism in DEX-treated female rat liver microsomes, and the apparent K(i) values were 0.088 and 91.2 microM, respectively. The values were similar to those in humans, suggesting that DEX-treated female rat liver microsomes have properties similar to those of humans. 4. After oral administration of midazolam, the plasma midazolam concentration in DEX-treated female rats significantly decreased compared with control female rats. The area under the plasma concentration curve (AUC) and elimination half-life were one-11th and one-20th of those of control female rats, respectively. 5. Using DEX-treated female rats, the effect of CYP3A inhibitors on midazolam pharmacokinetics was evaluated. The AUC and maximum concentration in plasma (C(max)) increased when ketoconazole was co-administered with midazolam. 6. It was shown that the drug-drug interaction that occurs in vitro is also observed in vivo after oral administration of midazolam. In conclusion, the DEX-treated female rat could be a useful model for evaluating drug-drug interactions based on CYP3A enzyme inhibition." @default.
• W2022359041 created "2016-06-24" @default.
• W2022359041 creator A5005045397 @default.
• W2022359041 creator A5016129923 @default.
• W2022359041 creator A5031417540 @default.
• W2022359041 creator A5059016094 @default.
• W2022359041 creator A5089966881 @default.
• W2022359041 date "2004-05-01" @default.
• W2022359041 modified "2023-10-18" @default.
• W2022359041 title "Model for the drug–drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats" @default.
• W2022359041 cites W161985329 @default.
• W2022359041 cites W1700470441 @default.
• W2022359041 cites W1969979837 @default.
• W2022359041 cites W1995775947 @default.
• W2022359041 cites W2005507744 @default.
• W2022359041 cites W2017616694 @default.
• W2022359041 cites W2022628424 @default.
• W2022359041 cites W2040869398 @default.
• W2022359041 cites W2050450820 @default.
• W2022359041 cites W2070268797 @default.
• W2022359041 cites W2085690957 @default.
• W2022359041 cites W2097502628 @default.
• W2022359041 cites W2104093795 @default.
• W2022359041 cites W2127059331 @default.
• W2022359041 cites W2163919962 @default.
• W2022359041 cites W4241401467 @default.
• W2022359041 cites W51748036 @default.
• W2022359041 cites W1988569722 @default.
• W2022359041 doi "https://doi.org/10.1080/00498250410001685746" @default.
• W2022359041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15370957" @default.
• W2022359041 hasPublicationYear "2004" @default.
• W2022359041 type Work @default.
• W2022359041 sameAs 2022359041 @default.
• W2022359041 citedByCount "21" @default.
• W2022359041 countsByYear W20223590412012 @default.
• W2022359041 countsByYear W20223590412013 @default.
• W2022359041 countsByYear W20223590412014 @default.
• W2022359041 countsByYear W20223590412015 @default.
• W2022359041 countsByYear W20223590412016 @default.
• W2022359041 countsByYear W20223590412017 @default.
• W2022359041 countsByYear W20223590412022 @default.
• W2022359041 crossrefType "journal-article" @default.
• W2022359041 hasAuthorship W2022359041A5005045397 @default.
• W2022359041 hasAuthorship W2022359041A5016129923 @default.
• W2022359041 hasAuthorship W2022359041A5031417540 @default.
• W2022359041 hasAuthorship W2022359041A5059016094 @default.
• W2022359041 hasAuthorship W2022359041A5089966881 @default.
• W2022359041 hasConcept C112705442 @default.
• W2022359041 hasConcept C11824378 @default.
• W2022359041 hasConcept C126322002 @default.
• W2022359041 hasConcept C134018914 @default.
• W2022359041 hasConcept C150903083 @default.
• W2022359041 hasConcept C181199279 @default.
• W2022359041 hasConcept C185592680 @default.
• W2022359041 hasConcept C207001950 @default.
• W2022359041 hasConcept C2776814716 @default.
• W2022359041 hasConcept C2777056448 @default.
• W2022359041 hasConcept C2778000748 @default.
• W2022359041 hasConcept C2779548794 @default.
• W2022359041 hasConcept C2780035454 @default.
• W2022359041 hasConcept C2781064554 @default.
• W2022359041 hasConcept C526171541 @default.
• W2022359041 hasConcept C55493867 @default.
• W2022359041 hasConcept C62231903 @default.
• W2022359041 hasConcept C71924100 @default.
• W2022359041 hasConcept C86803240 @default.
• W2022359041 hasConcept C87644729 @default.
• W2022359041 hasConcept C89311334 @default.
• W2022359041 hasConcept C89423630 @default.
• W2022359041 hasConcept C97320921 @default.
• W2022359041 hasConcept C98274493 @default.
• W2022359041 hasConceptScore W2022359041C112705442 @default.
• W2022359041 hasConceptScore W2022359041C11824378 @default.
• W2022359041 hasConceptScore W2022359041C126322002 @default.
• W2022359041 hasConceptScore W2022359041C134018914 @default.
• W2022359041 hasConceptScore W2022359041C150903083 @default.
• W2022359041 hasConceptScore W2022359041C181199279 @default.
• W2022359041 hasConceptScore W2022359041C185592680 @default.
• W2022359041 hasConceptScore W2022359041C207001950 @default.
• W2022359041 hasConceptScore W2022359041C2776814716 @default.
• W2022359041 hasConceptScore W2022359041C2777056448 @default.
• W2022359041 hasConceptScore W2022359041C2778000748 @default.
• W2022359041 hasConceptScore W2022359041C2779548794 @default.
• W2022359041 hasConceptScore W2022359041C2780035454 @default.
• W2022359041 hasConceptScore W2022359041C2781064554 @default.
• W2022359041 hasConceptScore W2022359041C526171541 @default.
• W2022359041 hasConceptScore W2022359041C55493867 @default.
• W2022359041 hasConceptScore W2022359041C62231903 @default.
• W2022359041 hasConceptScore W2022359041C71924100 @default.
• W2022359041 hasConceptScore W2022359041C86803240 @default.
• W2022359041 hasConceptScore W2022359041C87644729 @default.
• W2022359041 hasConceptScore W2022359041C89311334 @default.
• W2022359041 hasConceptScore W2022359041C89423630 @default.
• W2022359041 hasConceptScore W2022359041C97320921 @default.
• W2022359041 hasConceptScore W2022359041C98274493 @default.
• W2022359041 hasIssue "5" @default.
• W2022359041 hasLocation W20223590411 @default.
• W2022359041 hasLocation W20223590412 @default.

• next